ZA957703B - Method for the preparation of 3-hydroxy-5-[2-(dimethyl-amino)-ethyl]2,3-digydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds - Google Patents

Method for the preparation of 3-hydroxy-5-[2-(dimethyl-amino)-ethyl]2,3-digydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds

Info

Publication number
ZA957703B
ZA957703B ZA957703A ZA957703A ZA957703B ZA 957703 B ZA957703 B ZA 957703B ZA 957703 A ZA957703 A ZA 957703A ZA 957703 A ZA957703 A ZA 957703A ZA 957703 B ZA957703 B ZA 957703B
Authority
ZA
South Africa
Prior art keywords
active compounds
pharmaceutically active
product
benzothiazepin
methoxyphenyl
Prior art date
Application number
ZA957703A
Other languages
English (en)
Inventor
Martti Hytoenen
Original Assignee
Orion Corp Fermion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp Fermion filed Critical Orion Corp Fermion
Publication of ZA957703B publication Critical patent/ZA957703B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA957703A 1994-09-16 1995-09-13 Method for the preparation of 3-hydroxy-5-[2-(dimethyl-amino)-ethyl]2,3-digydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds ZA957703B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94114643A EP0702009B1 (en) 1994-09-16 1994-09-16 Method for the preparation of pharmaceutically active benzothiazepine derivatives

Publications (1)

Publication Number Publication Date
ZA957703B true ZA957703B (en) 1996-04-24

Family

ID=8216292

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957703A ZA957703B (en) 1994-09-16 1995-09-13 Method for the preparation of 3-hydroxy-5-[2-(dimethyl-amino)-ethyl]2,3-digydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds

Country Status (20)

Country Link
US (1) US5663332A (sh)
EP (1) EP0702009B1 (sh)
JP (1) JPH08269026A (sh)
AT (1) ATE167858T1 (sh)
BA (1) BA95040A (sh)
CA (1) CA2158223A1 (sh)
CZ (1) CZ290970B6 (sh)
DE (1) DE69411387T2 (sh)
DK (1) DK0702009T3 (sh)
EE (1) EE03565B1 (sh)
ES (1) ES2118292T3 (sh)
HR (1) HRP950478B1 (sh)
HU (1) HU220610B1 (sh)
IL (1) IL115275A (sh)
LV (1) LV11324B (sh)
PL (1) PL310495A1 (sh)
RU (1) RU2141957C1 (sh)
SK (1) SK281219B6 (sh)
YU (1) YU60395A (sh)
ZA (1) ZA957703B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996038429A1 (en) * 1995-06-01 1996-12-05 Acic (Canada) Inc. Method for the manufacture of benzothiazepine derivatives
IL123352A0 (en) * 1997-02-27 1998-09-24 Tanabe Seiyaku Co Process for preparing an optically active trans-3-substituted glycidic acid ester
DE102004010830A1 (de) * 2004-02-27 2005-09-15 Bioagency Ag Neue 1,4-Benzooxazepane oder 1,4-Benzothiazepane und Derivate
CN103304514B (zh) * 2013-06-28 2014-09-17 天津梅花医药有限公司 一种稳定性好的盐酸地尔硫卓化合物及药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法
IT1175814B (it) * 1984-03-09 1987-07-15 Luso Farmaco Inst Resine solfoniche ad attivita' terapeutica,loro preparazione e composizioni farmaceutiche che le contengono
JPS63275572A (ja) * 1987-05-01 1988-11-14 Tanabe Seiyaku Co Ltd １，５−ベンゾチアゼピン誘導体
FR2624117B1 (fr) * 1987-12-08 1991-02-22 Synthelabo Derives de hydroxy-3 (methoxy-4 phenyl)-2 (methylamino-2 ethyl)-5 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
FR2630109B1 (fr) * 1988-04-19 1991-11-29 Synthelabo Derives de ((n-(amino-2 oxo-2 ethyl)methylamino)-2 ethyl)-5 hydroxy-3 (methoxy-4 phenyl)-2 dihydro-2,3 5h-benzothiazepine-1,5 one-4, leur preparation et leur application en therapeutique
US5002942A (en) * 1988-07-25 1991-03-26 Sankyo Company, Limited 1,5-benzothiazepine derivatives, their preparation and their use in the treatment of cardiovascular disorders
FR2653122B1 (fr) * 1989-10-17 1994-04-15 Synthelabo Derives de 5-[2-[[2-amino-2-oxoethyl]methylamino]ethyl]-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepine-4-one, leur preparation et leur application en therapeutique.
IT1240686B (it) * 1990-04-27 1993-12-17 Luso Farmaco Inst Derivati 1,5-benzotiazepinonici, loro preparazione e uso farmaceutico
IT1244878B (it) * 1990-12-11 1994-09-12 Lusochimica Spa Processo per la preparazione del (+)-cis-3-(acetossi)-5-!2-( dimetilammino)etil!-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin- 4-(5h)-one cloridrato

Also Published As

Publication number Publication date
LV11324B (en) 1996-10-20
LV11324A (lv) 1996-06-20
ATE167858T1 (de) 1998-07-15
HRP950478B1 (en) 1999-10-31
HUT76924A (hu) 1998-01-28
CA2158223A1 (en) 1996-03-17
DK0702009T3 (da) 1999-02-01
EP0702009B1 (en) 1998-07-01
HU9502710D0 (en) 1995-11-28
CZ290970B6 (cs) 2002-11-13
US5663332A (en) 1997-09-02
RU2141957C1 (ru) 1999-11-27
EP0702009A1 (en) 1996-03-20
IL115275A0 (en) 1995-12-31
ES2118292T3 (es) 1998-09-16
CZ237295A3 (en) 1996-04-17
BA95040A (bs) 1998-12-28
IL115275A (en) 2000-06-01
HU220610B1 (hu) 2002-03-28
EE03565B1 (et) 2001-12-17
HRP950478A2 (en) 1997-06-30
YU60395A (sh) 1998-09-18
JPH08269026A (ja) 1996-10-15
SK281219B6 (sk) 2001-01-18
DE69411387D1 (de) 1998-08-06
SK114195A3 (en) 1996-06-05
EE9500050A (et) 1996-04-15
DE69411387T2 (de) 1999-02-25
PL310495A1 (en) 1996-03-18

Similar Documents

Publication Publication Date Title
CA2295792A1 (en) A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent
KR900003369B1 (ko) 나프토 티아제핀온
HK1039618B (zh) 製備11-氨基-3-氯-6，11-二氫-5，5-二氧代-6-甲基-二苯並[c，f][1，2]硫氮雜䓬的新方法及其合成噻萘普丁的應用
ZA957703B (en) Method for the preparation of 3-hydroxy-5-[2-(dimethyl-amino)-ethyl]2,3-digydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one and use of the product for making pharmaceutically active compounds
HUT46917A (en) Process for producing new 2-thiazolyl-imidazo/1,2-a/pyrimidines and their acid-addition salts and pharmaceutics comprising these compounds
IL76538A0 (en) Alkylpiperazino substituted indane derivatives and methods of preparation and treatment and pharmaceutical compositions containing them
EP0768311A4 (en) PYRROLOCARBAZOLE DERIVATIVES
ES8800920A1 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
HUT45518A (en) Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds
CA2379294A1 (en) Process for preparing dibenzothiazepine derivatives
GB2306957B (en) Preparation of a purified 3,4-epoxycyclohexyl methyl(meth)acrylate & a process for preparing a stabilized 3,4-epoxycyclohexyl methyl(meth)acrylate composition
ES2039166A1 (es) Proceso para la preparacion de benzodiacepinas por ciclizacion con acidos fosfonicos.
CA1291134C (en) Process for preparing 1,5-benzothiazepine derivatives
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
HU9500321D0 (en) Process for the preparation of 2,2'-dimorpholino-diethylether by reducing, catalytic amination of diethyleneglycol by morpholine
IL100157A0 (en) Preparation of a 1,5-benzothiazepine derivative
KR890002073A (ko) 나프토티아제핀온
IL119650A0 (en) Process for preparing optically active salts of 1,5-benzothiazepine compounds
CA2056129A1 (en) Process for preparing 1,5-benzothiazepine derivative
JPS54126732A (en) Antidepressant containing 2-(3-aminopropoxy)diphenyl ether or its derivative